Company: NOEMW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004368
Chunk: 315

Company: CO2 Energy Transition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 315
---

or changing any provisions with respect to matters or questions arising under the warrant agreement as the parties to the warrant agreement
may deem necessary or desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants
under the warrant agreement and (b) all other modifications or amendments require the vote or written consent of at least 50% of
the then outstanding public warrants, provided that any amendment that solely affects the terms of the private placement units or any
provision of the warrant agreement solely with respect to the private placement units also requires at least a majority of the then outstanding
private placement units. Accordingly, we may amend the terms of the public warrants in a manner adverse to a holder if holders of at least
50% of the then outstanding public warrants approve of such amendment. Although our ability to amend the terms of the public warrants
with the consent of at least 50% of the then outstanding public warrants is unlimited, examples of such amendments could be amendments
to, among other things, increase the exercise price of the warrants, shorten the exercise period or decrease the number of shares of common
stock purchasable upon exercise of a warrant.

A provision of our warrant agreement may
make it more difficult for us to consummate an initial business combination.

Unlike some blank check companies,
if

(i)we issue additional shares of common stock or equity-linked
securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective
issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith
by our board of directors and, in the case of any such issuance to our sponsor or its affiliates, without taking into account any founder
shares held by our sponsor or their respective affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”),

(ii)the aggregate gross proceeds from such issuances represent
more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the
date of the completion of our initial business combination (net of redemptions), and

(iii)the volume weighted average trading price of shares of our
common stock during the 20 trading day period starting on the trading day prior to the day on which we consummate our initial business
combination (such price, the “Market Value”) is below $9.20 per share,

then the